Laura (Brod) Hameed retweeted
Join IRSF next Tue, Nov 24, at 1p ET for Rett in Focus: Anavex, Blarcamesine, and the Road Ahead.
Hear directly from @AnavexLifeSci about its planned Phase 3 study of blarcamesine, an investigational therapy in development for Rett syndrome.
Register: us02web.zoom.us/webinar/regi…
Laura (Brod) Hameed retweeted
Today, we reported our third quarter 2026 earnings and provided a corporate update. As we continue to advance our lead #genetherapy program in clinical evaluation for Rett syndrome, TSHA-102 remains generally well tolerated, with no severe treatment-related serious adverse events or dose-limiting toxicities observed across all 33 patients treated in our REVEAL Phase 1/2, pivotal and ASPIRE trials as of the November 2026 data cutoff. We also successfully completed our BLA-enabling PPQ manufacturing campaign, an important milestone as we advance toward a potential Biologics License Application submission for TSHA-102 in #RettSyndrome.
Learn more: ir.tayshagtx.com/news-releas…
Laura (Brod) Hameed retweeted
Taysha is pleased to be a sponsor of the International Rett Syndrome Foundation’s Strollathon events to help fundraise, advocate and accelerate research for #Rettsyndrome. Throughout the month of October, members of the #TayshaTeam were honored to join the Rett syndrome community in Strolls around the country to support IRSF’s mission. #RettSyndromeAwarenessMonth @Rettsyndrome
Laura (Brod) Hameed retweeted
In recognition of #RettSyndromeAwarenessMonth, the Taysha team had the privilege of meeting Rachael and learning about her daughter, Mya, who lives with #Rettsyndrome. Rachael discussed the everyday challenges of caring for a loved one with Rett syndrome and shared her perspective on what meaningful progress toward new treatment options could mean for Mya and their family. We are incredibly grateful to Rachael for sharing her family’s story so openly and for her dedication to raising awareness of Rett syndrome.
We also joined the International @Rettsyndrome Foundation’s 3rd annual #PurpleOut in support of families impacted by Rett syndrome!
Laura (Brod) Hameed retweeted
This week, IRSF's Chief Scientific & Medical Officer, Dominique Pichard, MD, and Jean Dehdashti, Program Manager, Research & Strategic Initiatives, attended the FDA's Rare Disease Drug Development Framework meeting at its White Oak campus on behalf of IRSF and the Rett community.
If you missed today's Rare Disease Framework Initiative meeting, the public docket is open until Dec. 11. Patients, advocates, industry & researchers are encouraged to submit comments & help shape rare disease drug development. federalregister.gov/document…
Laura (Brod) Hameed retweeted
Cell and gene therapies can change what’s possible for patients living with rare and severe diseases. Cost shouldn’t put that possibility out of reach.
CMS is expanding our Cell and Gene Therapy Access Model to help more Medicaid patients access these life-changing treatments. Learn more about the CGT 2.0 Model: go.cms.gov/CGT
At Cleveland Clinic today, CMS Innovation Center Director Abe Sutton, @DrOzCMS, and @FDA_KyleD announced that CMS will invite manufacturers of other cell and gene therapies to apply to the CGT Access Model. Learn more: go.cms.gov/CGT
Modernizing FDA's review process starts with listening. Acting Commissioner Kyle Diamantas joined @RareDiseases at the #NORDSummit Monday to discuss how patient voices are central to building a fit-for-purpose framework for #RareDisease therapies.
Acting @FDA Commissioner Kyle Diamantas, @FDA_KyleD, sat down for a fireside chat with #NORD President and CEO Pam Gavin to kick off the 2026 #NORDSummit, where he shared that the #FDA is committed to modernizing its review process and is relying on #RareDisease patient voices to help shape its fit-for-purpose regulatory framework. We appreciated the opportunity to break down what that will entail, and we're excited to be a partner in this crucial, timely mission.
Laura (Brod) Hameed retweeted
Today we announced new data that reinforce key differentiators of NGN-401 #genetherapy for #RettSyndrome, which are being presented at the European Society of Gene and Cell Therapy 33rd Annual Congress. Read more: bit.ly/4ze64th #ESGCT2026 #ESGCTHamburg2026
Laura (Brod) Hameed retweeted
The table is nearly full. Only 10 seats remain for Hope at the Table: New York!
🍽️ Reserve your seat before the evening sells out: rettsyndrome.org/hope_nyc
Laura (Brod) Hameed retweeted
Today we announced upcoming presentations highlighting key differentiators of our NGN-401 #genetherapy program for #RettSyndrome at the European Society of Gene and Cell Therapy 33rd Annual Congress. Read more: bit.ly/4i7SvUR #ESGCT2026 #ESGCTHamburg2026
Laura (Brod) Hameed retweeted
Please welcome Dr. Tim Feyma to the IRSF Board of Directors! 💜 Dr. Feyma has spent more than 15 years caring for individuals with Rett syndrome. We’re thrilled to have his experience & longstanding commitment to the Rett community helping guide our work.
Laura (Brod) Hameed retweeted
Emotional moment at a Pennsylvania high school yesterday after a student crowned Homecoming King surprised everyone by passing the honor to the runner-up.
Laura (Brod) Hameed retweeted
Patients living with rare disease often cannot be served by traditional drug development paradigms. Today, BIO applauds the FDA for the launch of the Rare Disease Framework Initiative to develop a fit-for-purpose framework for rare disease drug development.
FDA is transforming rare disease drug approvals. The new Rare Disease Framework Initiative will work to give patients more voice, give developers more clarity, and eliminate surprises in the regulatory process. bloomberg.com/news/articles/…
Laura (Brod) Hameed retweeted
Huge day for rare disease! FDA just released "A New Framework for Rare Disease Review": fit-for-purpose evidence as the norm, consistent across review, patients built in. Not a lower bar. The right bar. 🦓 fda.gov/media/195694/downloa… #RareDisease
🤖 Made with AI
Laura (Brod) Hameed retweeted
💜 #DidYouKnow Specialized care can make a meaningful difference for individuals living with Rett syndrome and their families!
The IRSF's Center of Excellence Network connects families with clinics offering specialized, multidisciplinary care for individuals with Rett syndrome.
Laura (Brod) Hameed retweeted
Replying to @Rettsyndrome @lynchcreekfarm
Lynch Creek Farm offers beautiful evergreen wreaths, centerpieces, and other festive gifts designed to last throughout the holiday season. And the best part? 10% of every purchase comes back to IRSF to support Rett syndrome research. 💜
Laura (Brod) Hameed retweeted
Don't miss IRSF's next Rett in Focus Webinar, When Research Can't Answer Every Question, a 30-minute conversation about how expert consensus may help shape care in Rett syndrome when research alone does not provide clear guidance.
Laura (Brod) Hameed retweeted
💜 #DidYouKnow Rett syndrome affects BOTH boys and girls?
Because Rett syndrome is associated with changes in the MECP2 gene on the X chromosome, its symptoms and severity can vary between boys and girls. This left boys with Rett syndrome unseen, undiagnosed, or misdiagnosed.































